📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: NanoOnc

1.1 - Company Overview

NanoOnc Logo

NanoOnc

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of proprietary offerings, currently expanding operations in Madison, Wisconsin.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to NanoOnc

Egen Logo

Egen

HQ: United States Website
  • Description: Provider of safe, efficient delivery systems for the manufacture of nucleic acid and anti-cancer drugs and for creating products to treat human diseases, offering synthetic biocompatible delivery vehicles to deliver therapeutic genes, inhibitory RNA (siRNA & shRNA), and small molecules.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Egen company profile →
EG 427 Logo

EG 427

HQ: France Website
  • Description: Provider of pinpoint gene therapy using non-replicative HSV-1 vectors. Offers EG110A for neurogenic bladder dysfunction and overactive bladder; a platform delivering large genes with precise control and long-term expression for peripheral nervous system disorders; vector engineering with specific promoters for targeted sensory or autonomic neuronal subsets; and R&D expanding to chronic indications, including central nervous system neurons.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EG 427 company profile →
Akouos Logo

Akouos

HQ: United States Website
  • Description: Provider of AAV vector-based gene therapies to restore and preserve hearing in genetically defined patient populations, addressing causes from single gene mutations to ototoxic drug exposure and aging. Offers AK-OTOF, a gene therapy targeting sensorineural hearing loss due to otoferlin mutations, and the Resonate Program, no-cost genetic testing with optional counseling for auditory neuropathy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Akouos company profile →
Akamis Bio Logo

Akamis Bio

HQ: United Kingdom Website
  • Description: Provider of clinical-stage oncology therapeutics using its Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to develop viral vector-based gene therapies that target solid tumors and express therapeutic proteins to stimulate an immune response. Offerings include NG-350A (secreted CD40 agonist monoclonal antibody expressed within tumors), clinical trials of T-SIGn® agents, and collaborations with academia, research institutes, and biopharma.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Akamis Bio company profile →
DTx Pharma Logo

DTx Pharma

HQ: United States Website
  • Description: Provider of RNA-based therapeutic technologies aimed at treating genetic drivers of disease. Develops delivery approaches to enable personalized treatment across therapeutic areas, addressing limitations of earlier platforms such as poor pharmacokinetics and insufficient cellular uptake.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DTx Pharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for NanoOnc

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to NanoOnc

2.2 - Growth funds investing in similar companies to NanoOnc

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for NanoOnc

4.2 - Public trading comparable groups for NanoOnc

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to NanoOnc

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About NanoOnc

What does NanoOnc do?

NanoOnc is a provider of proprietary offerings, currently expanding operations in Madison, Wisconsin.

Who are NanoOnc's competitors?

NanoOnc's competitors and similar companies include Egen, EG 427, Akouos, Akamis Bio, and DTx Pharma.

Where is NanoOnc headquartered?

NanoOnc is headquartered in United States.

How many employees does NanoOnc have?

NanoOnc has 1,000 employees 🔒.

When was NanoOnc founded?

NanoOnc was founded in 2010 🔒.

What sector and industry vertical is NanoOnc in?

NanoOnc is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for NanoOnc

Who are the top strategic acquirers in NanoOnc's sector and industry

Top strategic M&A buyers and acquirers in NanoOnc's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for NanoOnc?

Top strategic M&A buyers groups and sectors for NanoOnc include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in NanoOnc's sector and industry vertical

Which are the top PE firms investing in NanoOnc's sector and industry vertical?

Top PE firms investing in NanoOnc's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in NanoOnc's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in NanoOnc's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in NanoOnc's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to NanoOnc include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in NanoOnc's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for NanoOnc?

The key public trading comparables and valuation benchmarks for NanoOnc include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for NanoOnc for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for NanoOnc with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in NanoOnc's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for NanoOnc with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in NanoOnc's' sector and industry vertical?

Access recent funding rounds and capital raises in NanoOnc's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for NanoOnc